Immunogenicity 10878
Sample ID
3678
Response
Negative
Tumor Type
Melanoma
Gene Symbol
HLA-B
Transcript ID
None
HLA INFO
B*44:02
TCR INFO
No TCR info found!
Full length protein sequence (362 aa)
MLVMA
1
PRTVL
6
LLLSA
11
ALALT
16
ETWAG
21
SHSMR
26
YFYTS
31
VSRPG
36
RGEPR
41
FISVG
46
YVDDT
51
QFVRF
56
DSDAA
61
SPREE
66
PRAPW
71
IEQEG
76
PEYWD
81
RNTQI
86
YKAQA
91
QTDRE
96
SLRNL
101
RGYYN
106
QSEAG
111
SHTLQ
116
SMYGC
121
DVGPD
126
GRLLR
131
GHDQY
136
AYDGK
141
DYIAL
146
NEDLR
151
SWTAA
156
DTAAQ
161
ITQRK
166
WEAAR
171
EAEQR
176
RAYLE
181
GECVE
186
WLRRY
191
LENGK
196
DKLER
201
ADPPK
206
THVTH
211
HPISD
216
HEATL
221
RCWAL
226
GFYPA
231
EITLT
236
WQRDG
241
EDQTQ
246
DTELV
251
ETRPA
256
GDRTF
261
QKWAA
266
VVVPS
271
GEEQR
276
YTCHV
281
QHEGL
286
PKPLT
291
LRWEP
296
SSQST
301
VPIVG
306
IVAGL
311
AVLAV
316
VVIGA
321
VVAAV
326
MCRRK
331
SSGGK
336
GGSYS
341
QAACS
346
DSAQG
351
SDVSL
356
TA
361
Mutation Information
DNA mutation:
None
Peptide Range:
211 ~ 235
Mut AA position:
223 (13 in Wild Type peptide)
Alignment
Wild Type:
"THVTHHPISDHEATLRCWALGFYPA
||||||||||||.||||||||||||
Mutant:
THVTHHPISDHEVTLRCWALGFYPA"
Clin Cancer Res, 2017
Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 ExpressionGene Name (from Reference) HLA-B
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
TILs
APC
Type
autologous DCs
Assay
ELISPOT assay